Switch to:
More From Other Websites
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll... Mar 24 2017
Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members Mar 23 2017
Moody's: Perrigo Filing Delay a "Credit Negative" Mar 20 2017
Perrigo Company plc -- Moody's: Perrigo's delayed 10-K filing is credit negative Mar 20 2017
PERRIGO CO PLC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing... Mar 17 2017
PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Mar 16 2017
Perrigo Provides Update On 2016 Form 10-K Filing Mar 16 2017
Perrigo Launches First to Market OTC Equivalent of Rogaine Mar 09 2017
RPI Finance Trust -- Moody's confirms RPI Finance Trust at Baa2; negative outlook Mar 09 2017
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine® Foam Mar 08 2017
Perrigo Provides 2016 Form 10-K Update Mar 07 2017
Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan Mar 07 2017
Perrigo Company PLC (PRGO) Becomes The Latest Pharma Investigated Over Price Fixing Mar 06 2017
Perrigo Joins Firms With Generic Drugs Under U.S. Glare Mar 03 2017
Perrigo Company PLC (PRGO) Drug Gets FDA Approval Mar 02 2017
Perrigo Company PLC (PRGO) Sells Rights To Tysabri Mar 01 2017
Five Companies to Benefit from Activist Starboard Value’s Involvement in 2017 Mar 01 2017
Pawar Law Group Announces Investigation of Securities Claims Against Perrigo Company plc - PRGO Mar 01 2017
EpiPen maker Mylan forecasts strong 2017; shares jump Mar 01 2017
Perrigo Announces FDA Final Approval For The Generic Version Of Axiron® Topical Solution, 30 mg/1.5... Mar 01 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK